2019 Dates Confirming Soon | Boston, MA



Corgenix is a global diagnostics company that commercializes liquid biopsy IVDs, for autoimmune, cardiovascular and liver diseases, using ELISA technology. Additionally, Corgenix has more than 20 years’ experience in ELISA contract manufacturing, serving the needs of Pharma and Diagnostic companies.  To support the increased demands for protein-based Liquid Biopsy Companion Diagnostics (LB-CDx), we have created a Personalized Diagnostics Team to develop and commercialize protein-based LB-CDx, in collaboration with Pharma and other Personalized Medicine stakeholders. Being platform agnostic allows Corgenix to develop IVDs that best meet our partners’ technical, clinical and commercial needs.